## Note
nid: 1472261886034
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#B&B::05_Cardio::04_Arrhythmias::06_Antiarrhythmic_Drugs, #AK_Step1_v11::#FirstAid::07_Cardiovascular::05_Pharm::12_16_Antiarrythmics::15_Class_4_Calcium_Channel_Blockers, #AK_Step1_v11::#OME::09_Cardiac::04_Electricity::05_Anti-Arrhythmics, #AK_Step1_v11::#OME_banner::Basic_Science::09_Cardiac::25_Arrhythmias, #AK_Step1_v11::#Physeo::09_Pharm::10_Cardiac::02_Calcium_Channel_Blockers, #AK_Step1_v11::#Physeo::09_Pharm::10_Cardiac::20_Class_IV_Antiarrhythmics, #AK_Step1_v11::#SketchyPharm::02_Cardio_&_Renal::04_Antiarrhythmics::04_Class_IV, #AK_Step1_v11::^Other::^HighYield::2-RelativelyHighYield, #AK_Step1_v11::^Systems::Cardio::Pharmacology, #AK_Step2_v11::#B&B::01_Cardiology::Pharm::CVS_Pharm_1
markdown: false

### Text
<div>
  What is the effect of <b>class IV antiarrhythmics</b>
  (non-dihydropyridine Ca<sup>2+</sup> channel blockers) on
  <b>effective refractory period</b>?
</div>
<div>
  {{c1::Increased ERP}}
</div>

### Extra


### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<div>
  <i>First Aid Pharmacology: Cardiovascular (Antiarrhythmics)</i>
</div><img src="paste-628710197690371.jpg"><img src=
"paste-640418278539267.jpg">

### Sketchy
<img src="Screen%20Shot%202019-09-25%20at%209.11.18%20AM.png">
<img src="Screen%20Shot%202019-09-25%20at%209.11.30%20AM.png">
<a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-cardiovascular-renal/videos/medical-pharmacology-cardiovascular-and-renal-antiarrhythmics-class-iv?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Class IV</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/cardiac/arrhythmias/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_4.png"></a>
</div>

### Additional Resources


### One by one

